The Food and Drug Administration (FDA) announced the approval of RotaTeq, a live, oral, vaccine for use in preventing rotavirus gastroenteritis in infants. It is the only vaccine approved in the United States that can help protect against rotavirus, a viral infection that may cause diarrhea, vomiting, fever, and dehydration.
Mrs. Suman, 32 years, average height and thin built, wheatish complexioned, consulted on 7-6-04 for the following complaints:
The FDA approved Amitiza (lubiprostone), the first drug of its chemical type, for the treatment of chronic constipation in the adult population where there is no known cause for the condition. The product will be available as capsules for use by adults to treat idiopathic constipation cases not caused by other diseases or by use of medications.
The Food and Drug Administration (FDA) announced the approval of Ranexa (ranolazine), a new drug for the treatment of chronic angina. Ranexa, a new molecular entity (NME), is the first drug approved to treat chronic angina in over ten years. Although several pharmacological activities of ranolazine have been described, the precise way the drug works is not fully understood. Because Ranexa affects electrical conduction in the heart (prolong the QT interval), it should only be used by patients who have not responded to other anti-anginal (long-acting nitrates, calcium channel blockers and beta blockers) drugs.
Mrs. Kalawati, around 58 years old, was brought to me by her daughter on 18-01-05 in great distress with a severely distended abdomen. She had not passed stool since about a week and on asking also said that she had not passed any gas since few days though she had tried all sorts of churans for it. She had a constant feeling of rumbling in abdomen and had no appetite or thirst. If she were fed forcefully she would throw up. I suspected intestinal obstruction from the presentation.
Losing a modest amount of weight through dietary changes and increased physical activity reduces the occurrence of urinary incontinence (UI) in women with prediabetes, a condition in which blood glucose levels are higher than normal but not yet diabetic. This finding comes from a new study, published in the February issue of Diabetes Care, of women who participated in the Diabetes Prevention Program (DPP), a landmark clinical study funded by the National Institutes of Health (NIH).
A new report claims omega-3 fatty acid supplements can protect against exercise-induced bronchoconstriction (EIB) in asthma sufferers, adding to previous studies linking fish oil to lung health.
Heart attack patients should avoid the dietary supplement L-arginine based on a study that was scuttled after six volunteers taking the over-the-counter supplement d i ed, researchers.
A small study has shown that the osteoporosis drug raloxifene, sold as Evista, helps maintain bone mineral density (BMD) in menopausal women with systemic lupus erythematosus (SLE) who are on corticosteroids.
A large study on the popular asthma medication salmeterol was halted after researchers uncovered evidence that the drug may pose a slightly higher risk for respiratory and asthma-related deaths among black patients.